In Focus: cellular starting materials for cell therapies
Cellular starting materials are a crucial aspect in the development of cell therapies. However, starting materials that involve a cell preparation can be a significant source of variability when it comes to the final product, especially when considering donor-specific cells.
In our latest In Focus feature, produced in association with RheinCell Therapeutics (Langenfeld, Germany), we bring you expert insights into the advantages that various cellular starting materials have, with a particular focus on human induced pluripotent stem cells (iPSCs). We also explore the challenges of establishing iPSCs as starting materials for clinically relevant therapeutic development, as well as highlight the importance of starting materials as a catalyst for the commercial feasibility and economic practicality of cell therapies.
In association with: